体外受精中无外源性孕酮的黄体期支持:两项试点随机对照试验
两项开放标签试点随机对照试验纳入250例IVF患者,比较GnRHa触发后黄体期HCG bolus无阴道孕酮支持与HCG触发联合标准阴道孕酮支持。主要结局为每移植周期持续妊娠率,两组结果相近,无外源性孕酮方案被认为有效、简单且患者友好,但需更大规模研究验证。
要点
- GnRHa触发后HCG bolus无孕酮方案与标准方案持续妊娠率相近
- ≤13卵泡组持续妊娠率44% vs 46%,无OHSS发生
- 14-25卵泡组持续妊娠率51% vs 60%,OHSS率3.3% vs 6.7%
核心结论
- 无外源性孕酮的黄体期支持方案有效、简单且患者友好,但需更大规模研究支持常规临床实施。
研究设计与样本
- 两项开放标签试点随机对照试验,2014至2019年共纳入250例IVF患者,主要结局为每胚胎移植的持续妊娠率。
- RCT 1纳入触发日卵泡数≤13的患者,随机分为Group A(n=65,GnRHa触发后取卵日皮下注射1500 IU HCG及4天后1000 IU HCG,无阴道孕酮)和Group B(n=65,6500 IU HCG触发后标准阴道孕酮支持)。
- RCT 2纳入触发日卵泡数14-25的患者,随机分为Group C(n=60,GnRHa触发后取卵日皮下注射1000 IU HCG及4天后500 IU HCG,无阴道孕酮)和Group D(n=60,6500 IU HCG触发后标准阴道孕酮支持)。
主要发现
- RCT 1中GnRHa组持续妊娠率为44%(22/50),HCG触发组为46%(25/54),RR 0.95(95% CI 0.62-1.45)。
- RCT 1中Group A和Group B均未见卵巢过度刺激综合征(OHSS)。
- RCT 2中GnRHa组持续妊娠率为51%(25/49),HCG触发组为60%(31/52),RR 0.86(95% CI 0.60-1.22)。
- RCT 2中OHSS发生率分别为3.3%和6.7%。
临床怎么用
- 对于IVF患者,GnRHa触发后采用黄体期HCG bolus替代外源性孕酮的黄体期支持方案可能可行,但当前证据尚不足以常规临床推广。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Is the reproductive outcome similar after gonadotrophin-releasing hormone agonist (GnRHa) trigger followed by luteal human chorionic gonadotrophin (HCG) boluses compared with HCG trigger and a standard luteal phase support (LPS)? DESIGN: Two open-label pilot randomized controlled trials (RCT) with 250 patients from 2014 to 2019, with a primary outcome of ongoing pregnancy per embryo transfer. Patients with ≤13 follicles on the trigger day were randomized (RCT 1) to: Group A (n = 65): GnRHa trigger followed by a bolus of 1500 IU HCG s.c. on the oocyte retrieval day (ORD) and 1000 IU HCG s.c. 4 days later, and no vaginal LPS; or Group B (n = 65): 6500 IU HCG trigger, followed by a standard vaginal progesterone LPS. Patients with 14-25 follicles on the trigger day were randomized (RCT 2) to Group C (n = 60): GnRHa trigger followed by 1000 IU HCG s.c. on ORD and 500 IU HCG s.c. 4 days later, and no vaginal LPS; or Group D (n = 60): 6500 IU HCG trigger and a standard vaginal LPS. RESULTS: In RCT 1, the ongoing pregnancy rate was 44% (22/50) in the GnRHa group versus 46% (25/54) in the HCG trigger group (RR 0.95, 95% CI 0.62-1.45). No ovarian hyperstimulation syndrome (OHSS) was seen in Groups A or B. In RCT 2, the ongoing pregnancy rate was 51% (25/49) in the GnRHa group versus 60% (31/52) in the HCG trigger group (RR 0.86, 95% CI 0.60-1.22). The OHSS rates were 3.3% and 6.7%, respectively. CONCLUSIONS: Although a larger-scale study is needed before standard clinical implementation, the present study supports that the exogenous progesterone-free LPS is efficacious, simple and patient-friendly.
引用
- Humaidan P, Alsbjerg B, Elbaek HO, et al. The exogenous progesterone-free luteal phase: two pilot randomized controlled trials in IVF patients. Reprod Biomed Online. 2021. PMID: 33931371. doi:10.1016/j.rbmo.2021.03.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。